Revelation Biosciences REVB
NASDAQ REVB
$0.80 -0.02 (-1.96%)
As of: Oct 1, 2026 · 3:59 PM EDT

Revelation Biosciences (REVB) Invested Capital (2020 - 2021)

Updated

Revelation Biosciences' Invested Capital was $674,875 in Q4 2021.

Analysis

Revelation Biosciences (REVB) Invested Capital (2020 - 2021) Analysis & Trends

  • The Q4 2021 figure marks the lowest quarterly Invested Capital since Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Revelation Biosciences 3.20 Mn -45.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 674,875.00
Sep 30, 2020 137,813.00
API Access

Revelation Biosciences Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=REVB&period=max&api_key=YOUR_API_KEY